LXRX
Lexicon Pharmaceuticals Inc
1.90$
-0.3%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -195.0% | – | – | – | -225.6% | – | – | – | – | – | |
| – | -62.3% | +182.8% | +65.3% | +8.4% | -0.8% | -19.7% | -90.0% | +46.2% | +29.7% | -3.6% | +16.3% | |
| – | -3.4% | +8.9% | +27.1% | +23.5% | +21.6% | -6.6% | -20.3% | +8.9% | +24.5% | -5.9% | -7.3% | |
| – | -19.8% | -58.5% | -116.0% | – | -29.9% | +53.2% | -15.4% | +8.4% | – | – | – | |
| – | +7,399.6% | -125.3% | – | – | – | – | -132.9% | – | +561.4% | +435.5% | -288.9% | |
| – | +1,037.5% | -74.6% | -1.3% | -58.3% | -26.3% | +24.3% | +1,303.4% | +8.6% | -64.6% | +119.4% | -100.0% | |
| – | +7.9% | – | +176.8% | +235.6% | -191.9% | – | -99.4% | -3,468.6% | -29.7% | -69.2% | – | |
| – | – | – | -100.0% | – | – | – | -94.6% | – | – | – | – | |
| – | -59.8% | +73.9% | +170.4% | -42.1% | -3.2% | +9.0% | +160.7% | -67.7% | -4.6% | +110.0% | -66.9% | |
| – | -102.3% | +8.4% | – | -101.4% | -35.9% | +16,754.5% | -94.6% | – | +2.2% | -100.0% | – | |
| – | -100.7% | – | +15,090.8% | -101.5% | -0.8% | +6,532.3% | – | +526.2% | +32.2% | +26.8% | -120.3% | |
| – | -34.1% | -338.0% | – | +24.3% | -336.4% | – | -169.0% | – | – | – | -107.5% | |
| – | – | -195.6% | – | – | – | -225.8% | – | – | – | – | – |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.